| 1 |
33900042 | Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapy. | 2022 Jan |
1 |
| 2 |
34874743 | Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity. | 2022 Jan 25 |
3 |
| 3 |
35110416 | Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer. | 2022 May 2 |
1 |
| 4 |
35147047 | Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients. | 2022 Apr |
2 |
| 5 |
29090664 | Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia. | 2018 |
1 |
| 6 |
30351207 | Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. | 2018 Nov |
1 |
| 7 |
23441093 | Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. | 2013 Aug |
1 |